ALK and neuroblastoma: Recent ultradeep sequencing of diagnostic tumors from patients with high-risk neuroblastoma demonstrates that oncogenic aberrations are more prevalent than previously recognized, with 25% harboring an activating ALK mutation or gene amplification20.